%0 Journal Article
%K Adrenal Cortex Hormones/therapeutic use
%K Aged
%K Aged, 80 and over
%K Bronchodilator Agents/adverse effects
%K Delivery of Health Care
%K Disease Progression
%K England/epidemiology
%K Female
%K Humans
%K Male
%K Middle Aged
%K Muscarinic Antagonists/adverse effects
%K *Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/epidemiology
%K Retrospective Studies
%K Global Initiative for Chronic Obstructive Lung Disease
%K chronic obstructive lung disease
%K Database
%K exacerbations
%K healthcare costs
%K Maintenance therapy
%B Int J Chron Obstruct Pulmon Dis
%D 2021
%G eng
%M 34552325
%P 2591-2604
%R 10.2147/copd.s318969
%T Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
%V 16
%2 PMC8450675
%7 2021/09/24
%@ 1176-9106 (Print)1176-9106